Epigenetics in cardiovascular disease. 1st ed. (Book)

March 06, 2021 By:
  • Devaux Y
  • Robinson E.

Epigenetics in Cardiovascular Disease, a new volume in the Translational Epigenetics series, offers a comprehensive overview of the epigenetics mechanisms governing cardiovascular disease development, as well as instructions in research methods and guidance in pursing new studies. More than thirty international experts provide an (i) overview of the epigenetics mechanisms and their contribution to cardiovascular disease development, (i) high-throughput methods for RNA profiling including single-cell RNA-seq, (iii) the role of nucleic acid methylation in cardiovascular disease development, (iv) epigenetic actors as biomarkers and drug targets, (v) and the potential of epigenetics to advance personalized medicine. Here, readers will discover strategies to combat research challenges, improve quality of their epigenetic research and reproducibility of their findings. Additionally, discussion of assay and drug development for personalized healthcare pave the way for a new era of understanding in cardiovascular disease.

2021 Mar. Elsevier Science, 2021. 498 p. (Translational Epigenetics, Vol.24). ISBN 978-0-12-822258-4 (Paperback ISBN); 978-0-12-822259-1 (eBook ISBN).
Other information